The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen-Reference-Cited by-同舟云学术

The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen

Published:2018-04 Issue:4 Volume:68 Page:646-654
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Innes Hamish,Barclay Stephen T.,Hayes Peter C.,Fraser Andrew,Dillon John F.,Stanley Adrian,Bathgate Andy,McDonald Scott A.,Goldberg David,Valerio Heather,Fox Ray,Kennedy Nick,Bramley Pete,Hutchinson Sharon J.

Publisher

Elsevier BV

Subject

Hepatology

Reference22 articles.

1. Hepatitis C virus therapeutic development: in pursuit of “perfectovir”;Dore;Clin Infect Dis,2015

2. Safety and efficacy of elbasvir/gazoprevir in patients with hepatitis C virus infection and compensated cirrhosis: an integrated analysis;Jacobson;Gastroenterology,2017

3. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;Van der Meer;JAMA,2012

4. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings;Rein;Ann Intern Med,2012

5. Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy;Reig;J Hepatol,2016

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis;Hepatology International;2024-07-05

2. Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC‐MS/MS cancer cell entrapment assays;Chemical Biology & Drug Design;2024-03

3. The Role of Circular RNA Variants Generated from the NFIX Gene in Different Diseases;Molecular Pharmaceutics;2024-02-05

4. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01

5. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?;Viruses;2023-12-17